Advertisement
UK markets close in 4 hours 12 minutes

  • FTSE 100

    7,859.72
    +11.73 (+0.15%)
     

  • FTSE 250

    19,401.25
    +61.11 (+0.32%)
     

  • AIM

    744.19
    +1.07 (+0.14%)
     

  • GBP/EUR

    1.1688
    +0.0021 (+0.18%)
     

  • GBP/USD

    1.2479
    +0.0023 (+0.18%)
     

  • Bitcoin GBP

    50,120.40
    -458.35 (-0.91%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • S&P 500

    5,022.21
    -29.20 (-0.58%)
     

  • DOW

    37,753.31
    -45.66 (-0.12%)
     

  • CRUDE OIL

    81.93
    -0.76 (-0.92%)
     

  • GOLD FUTURES

    2,397.30
    +8.90 (+0.37%)
     

  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     

  • HANG SENG

    16,385.87
    +134.03 (+0.82%)
     

  • DAX

    17,779.00
    +8.98 (+0.05%)
     

  • CAC 40

    8,013.80
    +32.29 (+0.40%)
     
Money:

Best mortgage deals of the week

As possibility of multiple interest rate cuts dwindle here's what banks and building societies are offering

$31.5 Billion Worldwide Single-Use Bioprocessing Industry to 2027 - Featuring Applikon Biotechnology, Boehringer Ingelheim and Cesco Bioengineering Among Others

Research and Markets
·7-min read
Company Logo
Company Logo

Global Single-Use Bioprocessing Market

Global Single-Use Bioprocessing Market
Global Single-Use Bioprocessing Market

Dublin, July 15, 2022 (GLOBE NEWSWIRE) -- The "Single-Use Bioprocessing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

The global single-use bioprocessing market reached a value of US$ 12.2 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 31.5 Billion by 2027, exhibiting a CAGR of 17.13% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Single-use bioprocessing, or disposables, consists of various pharmaceutical solutions and products that are designed to be used once and then discarded. Media bags, containers, filtration assemblies, single-use bioreactors, disposable mixers, tubes, connectors and samplers are some of the most commonly used single-use bioprocessing products. These products are often used in the production of monoclonal antibodies, vaccines, plant cell cultivation and specific cell therapies. They are also utilized by biopharmaceutical manufacturers and life science research organizations for increasing productivity and ease of disposal with minimal risk of cross-contamination.

The increasing demand for pharmaceutical products across the globe is one of the key factors driving the growth of the market. The single-use bioprocessing technology is commonly used in media preparation and shipping of biologics while manufacturing pharmaceuticals.

ADVERTISEMENT

Furthermore, there is a growing preference for single-use products manufactured using high-grade polymer materials and plastic composites as they offer enhanced integral strength and aid in reducing the overall operational costs. It also ensures continuity in biomanufacturing, which is further providing a boost to the market growth.

Additionally, various technological advancements, including the utilization of automation, big data and machine learning (ML) solutions in bioprocessing, are creating a positive outlook for the market growth. Such technological solutions aid in developing analytical models for predicting errors and improving accuracy during medical procedures. Other factors, including significant developments in the healthcare sector and extensive research and development (R&D) activities, are projected to drive the market further.

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Applikon Biotechnology, Boehringer Ingelheim, Cesco Bioengineering Company, Corning Inc., Danaher Corporation, Entegris, Eppendorf AG, Finesse Solutions Inc., GE Healthcare, Infors, Merck Millipore, Rentschler Biotechnologie, Sartorius Stedim Biotech, Thermo Fisher Scientific, 3M Company, etc.

Key Questions Answered in This Report:

  • How has the global single-use bioprocessing market performed so far and how will it perform in the coming years?

  • What are the key regional markets?

  • What has been the impact of COVID-19 on the global single-use bioprocessing market?

  • What is the breakup of the market based on the product type?

  • What is the breakup of the market based on the application?

  • What is the breakup of the market based on the end-use?

  • What is the breakup of the market based on the end-user?

  • What are the various stages in the value chain of the industry?

  • What are the key driving factors and challenges in the market?

  • What is the structure of the global single-use bioprocessing market and who are the key players?

  • What is the degree of competition in the market?

Key Topics Covered:

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Single-Use Bioprocessing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product Type
6.1 Media Bags and Containers
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Filtration Assemblies
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Single-Use Bioreactors
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Disposable Mixers
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast

7 Market Breakup by Application
7.1 Filtration
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Storage
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Cell Culture
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Mixing
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Purification
7.5.1 Market Trends
7.5.2 Market Forecast

8 Market Breakup by End-Use
8.1 Upstream
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Fermentation
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Downstream
8.3.1 Market Trends
8.3.2 Market Forecast

9 Market Breakup by End-User
9.1 Biopharmaceutical Manufacturers
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Life Science R&D
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast

10 Market Breakup by Region

11 SWOT Analysis

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Applikon Biotechnology
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Boehringer Ingelheim
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Cesco Bioengineering Company
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Corning Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Danaher Corporation
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Entegris
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Eppendorf AG
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Finesse Solutions Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 GE Healthcare
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 SWOT Analysis
14.3.10 Infors
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Merck Millipore
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Rentschler Biotechnologie
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.13 Sartorius Stedim Biotech
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.13.3 Financials
14.3.13.4 SWOT Analysis
14.3.14 Thermo Fisher Scientific Inc.
14.3.14.1 Company Overview
14.3.14.2 Product Portfolio
14.3.14.3 Financials
14.3.14.4 SWOT Analysis
14.3.15 3M Company
14.3.15.1 Company Overview
14.3.15.2 Product Portfolio
14.3.15.3 Financials
14.3.15.4 SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/p70irk

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900